Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-05-01 13:40 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
416,665 | |
Filed 2023-05-01 13:39 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,632 vol |
402,387 | |
Filed 2023-04-05 16:11 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$57,600
+640,000 vol $0.09 each |
640,000 | |
Filed 2023-04-05 16:10 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-03-31 13:50 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,450
+28,829 vol $0.085 each |
410,033 | |
Filed 2023-03-31 13:49 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,829 vol |
409,019 | |
Filed 2023-03-30 11:25 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-86,174 vol |
0 | |
Filed 2023-03-30 11:24 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-86,174 vol |
437,848 | |
Filed 2023-03-30 11:22 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-76,388 vol |
417,730 | |
Filed 2023-01-26 12:26 Tx date 2022-12-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+338,097 vol |
524,022 | |
Filed 2023-01-26 12:24 Tx date 2022-12-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,174 vol |
185,925 | |
Filed 2023-01-26 12:20 Tx date 2022-12-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+86,174 vol |
86,174 | |
Filed 2023-01-26 12:12 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-01-26 12:10 Tx date 2022-12-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+76,388 vol |
494,118 | |
Filed 2022-11-14 10:37 Tx date 2022-11-11 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,500
+100,000 vol $0.135 each |
381,204 | |
Filed 2022-05-05 12:20 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,724
+6,633 vol $0.26 each |
281,204 | |
Filed 2022-05-05 12:18 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,633 vol |
99,751 | |
Filed 2022-04-25 14:23 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,486 vol |
106,384 | |
Filed 2022-04-25 14:21 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,730 vol |
417,730 | |
Filed 2021-05-03 19:00 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+19,898 vol |
19,898 | |
Filed 2021-05-03 19:00 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-03 18:59 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,188
+48,000 vol $1.61 each |
288,000 | |
Filed 2020-06-10 19:12 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
240,000 | |
Filed 2020-06-10 19:11 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
||
Filed 2020-06-10 17:37 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
240,000 | |
Filed 2020-06-10 17:37 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
||
Filed 2019-08-02 12:12 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-6,589,715 vol |
274,571 | |
Filed 2019-08-02 12:11 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
Filed 2019-08-02 12:09 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-6,589,715 vol |
274,571 | |
Filed 2019-05-10 12:23 Tx date 2019-05-02 |
$MKNA
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000,000 vol |
5,000,000 | |
Filed 2019-05-10 12:23 Tx date 2019-04-12 |
$MKNA
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|